ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 2 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -98.3% | 237,610 | -81.0% | 0.00% | -100.0% |
| Q2 2022 | $239,000 | +753.6% | 1,250,988 | +6996.6% | 0.00% | – |
| Q2 2020 | $28,000 | -24.3% | 17,628 | +88.6% | 0.00% | – |
| Q3 2019 | $37,000 | -65.1% | 9,345 | -38.0% | 0.00% | – |
| Q1 2019 | $106,000 | +30.9% | 15,070 | +1.7% | 0.00% | – |
| Q4 2018 | $81,000 | -49.1% | 14,819 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $159,000 | -34.3% | 14,819 | -20.1% | 0.00% | 0.0% |
| Q2 2018 | $242,000 | – | 18,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,790,964 | $3,572,000 | 2.49% |
| AIGH Capital Management LLC | 2,000,000 | $2,560,000 | 1.04% |
| Worth Venture Partners, LLC | 510,200 | $653,000 | 0.52% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $4,263,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 269,836 | $345,000 | 0.07% |
| Anson Funds Management LP | 217,251 | $278,000 | 0.06% |
| Golden Green, Inc. | 39,000 | $50,000 | 0.05% |
| Point72 Asset Management, L.P. | 4,000,000 | $5,120,000 | 0.02% |
| PFM Health Sciences, LP | 284,285 | $364,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 158,800 | $203,000 | 0.00% |